U.S. Markets open in 1 hr 16 mins

VIVUS Inc. (VVUS) in Focus: Stock Rises 7.23%

Zacks Equity Research

VIVUS Inc. (VVUS) was a big mover last session, as the company saw its shares rally over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This broke the recent trend of the company, as the stock is now trading above the volatile price range of $4.84 to $5.36 in the past one-month time frame.

In the last 30 days, the company witnessed no estimate revisions, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.

VIVUS currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other attractive players in the healthcare industry include Enanta Pharmaceuticals, Inc. (ENTA), Gilead Sciences Inc. (GILD) and TrovaGene, Inc. (TROV) all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

VIVUS INC (VVUS): Free Stock Analysis Report


GILEAD SCIENCES INC (GILD): Free Stock Analysis Report

TROVAGENE NEW (TROV): Free Stock Analysis Report

Zacks Investment Research